Advanced search
Publication Cover
Patient Preference and Adherence Volume 9, 2015 - Issue
Submit an article Journal homepage
117
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis

Mingliang Zhang1 Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, USACorrespondence[email protected]
,
Susan K Brenneman2 Health Economics and Outcomes Research, Optum Life Sciences, Eden Prairie, MN, USA
,
Chureen T Carter1 Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, USA
,
Breanna L Essoi2 Health Economics and Outcomes Research, Optum Life Sciences, Eden Prairie, MN, USA
,
Kamyar Farahi1 Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, USA
,
Michael P Johnson2 Health Economics and Outcomes Research, Optum Life Sciences, Eden Prairie, MN, USA
,
Seina Lee1 Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, USA
&
William H Olson3 Research and Analysis Strategy, Janssen Scientific Affairs, LLC, Titusville, NJ, USA
 show all
Pages 777-784 | Published online: 16 Jun 2015

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Gemma Camiña-Conforto, Laura Mateu-Arrom, Anna López-Ferrer & Lluís Puig. (2023) Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives. Patient Preference and Adherence 17, pages 1541-1549.
Read now
Amy Rinaldi, Dimos Katsaros, James Hawthorne, Matthew D’Auria, Katherine Brigham, Erika Bajars, Chris Franzese & Marty Coyne. (2021) The current paradigm for biologic initiation: a mixed-methods exploration of practices, unmet needs, and innovation opportunities in self-injection training. Expert Opinion on Drug Delivery 18:8, pages 1151-1168.
Read now
Karin Luttropp, Johan Dalén, Axel Svedbom, Mary Dozier, Christopher M Black & Amy Puenpatom. (2020) Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review. Patient Preference and Adherence 14, pages 309-320.
Read now
Heather L Gelhorn, Zaneta Balantac, Christopher S Ambrose, Yen N Chung & Brian Stone. (2019) Patient and physician preferences for attributes of biologic medications for severe asthma. Patient Preference and Adherence 13, pages 1253-1268.
Read now
Francesco Pietrini, Umberto Albert, Andrea Ballerini, Paola Calò, Giuseppe Maina, Federica Pinna, Marco Vaggi, Ileana Boggian, Maria Fontana, Cesare Moro & Bernardo Carpiniello. (2019) The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia. Neuropsychiatric Disease and Treatment 15, pages 1045-1060.
Read now
Michael S. Heath, Sree S. Kolli, Jessica R. Dowling, Abigail Cline & Steven R. Feldman. (2019) Pharmacotherapeutic strategies for standard treatment-resistant psoriasis. Expert Opinion on Pharmacotherapy 20:4, pages 443-454.
Read now
Joseph S. Aleshaki, Leah A. Cardwell, Mikél E. Muse & Steven R. Feldman. (2018) Adherence and resource use among psoriasis patients treated with biologics. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 609-617.
Read now
Dongmei Wang, Jiangyong Gu, Wei Zhu, Fang Luo, Lirong Chen, Xiaojie Xu & Chuanjian Lu. (2017) PDTCM: a systems pharmacology platform of traditional Chinese medicine for psoriasis. Annals of Medicine 49:8, pages 652-660.
Read now
J. M. Carrascosa, P. de la Cueva, P. Herranz, J. Labandeira & J. Notario. (2017) Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians. Journal of Dermatological Treatment 28:3, pages 188-199.
Read now
Benjamin Farahnik, Viraat Patel, Kourosh Beroukhim, Tian Hao Zhu, Michael Abrouk, Mio Nakamura, Rasnik Singh, Kristina Lee, Tina Bhutani & John Koo. (2016) Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability. Psoriasis: Targets and Therapy 6, pages 105-111.
Read now

Articles from other publishers (12)

Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Annalise Hilts, Patrick Lefebvre & Steven R. Feldman. (2023) Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA. Dermatology and Therapy 13:4, pages 1053-1068.
Crossref
Alireza Abdshah, Mahboubeh Parsaeian, Maryam Nasimi & Maryam Ghiasi. (2022) Validating the “Treatment Satisfaction Questionnaire for Medication” in Persian and Evaluating Treatment Satisfaction Among Patients With Psoriasis. Value in Health Regional Issues 29, pages 16-20.
Crossref
Robabeh Abedini, Alireza Abdshah, Narges Ghandi, Atefe Janatalipour, Sara Torabi & Maryam Nasimi. (2022) Treatment satisfaction and response in patients with severe alopecia areata under treatment with diphenylcyclopropenone. Health Science Reports 5:3.
Crossref
Javier Sabater‐Abad, María Matellanes‐Palacios, Laia Bou‐Boluda, Francesc Messeguer‐Badia, Anna Agustí‐Mejias, Manuel Velasco‐Pastor, Laura Lorente‐Fernández & Enrique Gimeno‐Carpio. (2020) Efficacy and safety of adalimumab 80 mg in the treatment of psoriasis: a bicentric retrospective study. Dermatologic Therapy 33:3.
Crossref
M. Lebwohl, R.G. Langley, Y. Zhu, H. Zhou, M. Song, Y.K. Shen, K. Parnell Lafferty & K. Reich. (2019) Use of dose–exposure–response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis. Journal of the European Academy of Dermatology and Venereology 33:11, pages 2082-2086.
Crossref
L.S. van der Schoot, J.M.P.A. van den Reek, J.M.M. Groenewoud, M.E. Otero, M.D. Njoo, P.M. Ossenkoppele, J.M. Mommers, M.I.A. Koetsier, M.A.M. Berends, W.P. Arnold, B. Peters, M.P.M. Andriessen, C.W. Den Hengst, A.L.A. Kuijpers & E.M.G.J. de Jong. (2019) Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry. Journal of the European Academy of Dermatology and Venereology 33:10, pages 1913-1920.
Crossref
M. Elaine Husni, Anthony Fernandez, Brett Hauber, Rakesh Singh, Joshua Posner, Jessie Sutphin & Arijit Ganguli. (2018) Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study. Arthritis Research & Therapy 20:1.
Crossref
Juan Marcos Gonzalez. (2018) Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis. The Patient - Patient-Centered Outcomes Research 11:3, pages 285-300.
Crossref
Tiago Torres. (2017) Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab. Drugs 77:14, pages 1493-1503.
Crossref
I. Zschocke, C. Ortland & K. Reich. (2017) Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: the importance of physician-patient interaction and communication. Journal of the European Academy of Dermatology and Venereology 31:6, pages 1014-1020.
Crossref
Der Yi Hsu & Robert Gniadecki. (2016) Patient Adherence to Biologic Agents in Psoriasis. Dermatology 232:3, pages 326-333.
Crossref
Katrina Hutton Carlsen, Adel Olasz, Karen Marie Carlsen & Jørgen Serup. 2016. Adherence in Dermatology. Adherence in Dermatology 101 119 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.